Article info

Download PDFPDF

Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study

Authors

  1. Correspondence to Helen Strongman; helen.strongman{at}mhra.gov.uk
View Full Text

Citation

Strongman H, Korhonen P, Williams R, et al
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study

Publication history

  • Received November 17, 2016
  • Revised March 27, 2017
  • Accepted April 3, 2017
  • First published May 29, 2017.
Online issue publication 
May 29, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.